November 13, 2014 GREER® Laboratories Announces Rick Russell as New President and CEO
May 5, 2014 GREER® Laboratories, Inc. Launches ORALAIR®, the First and Only Sublingual Allergy Immunotherapy Tablet with a Mix of Five Grass Allergens for the Treatment of Grass Pollen Allergy
March 10, 2014 GREER® Investigational Sublingual Allergy Immunotherapy Liquid (SAIL)™ for Short Ragweed Allergies Phase III Data Published in Journal of Allergy and Clinical Immunology
December 12, 2013 FDA Advisory Committee Supports Approval of ORALAIR® for the Treatment of Grass Pollen Allergy
April 2013 USDA approves GREER® Extracts™ and GREER® Pharmacy Custom Prescriptions for Veterinary Sublingual Immunotherapy
Do you have a challenge or question you need help with right away? Get in touch with GREER®
Toll Free: 800.378.3906
All material and content herein Copyright © 2017 GREER. No material from this website may be used, reproduced or copied in whole or in part without prior written permission from GREER.All Rights Reserved Worldwide.